PharmacoEconomics and Outcomes News via MedWorm.com MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'PharmacoEconomics and Outcomes News' source. Thu, 09 Feb 2012 10:13:04 +0100 Eribulin is now available under national reimbursement in Italy for women with locally advanced or metastatic breast cancer http://www.medworm.com/index.php?rid=5672523&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00038 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672523 Thu, 09 Feb 2012 14:54:20 +0100 5672523 Despite steady growth in the number of coronary stenting procedures, the European coronary stent market is set to shrink to $US490 million by 2016 http://www.medworm.com/index.php?rid=5672522&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00037 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672522 Thu, 09 Feb 2012 14:54:20 +0100 5672522 Globally, the stem cell therapy market is expected to exceed $US700 million, and may even reach over $1 billion given some positive trends http://www.medworm.com/index.php?rid=5672521&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00036 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672521 Thu, 09 Feb 2012 14:54:20 +0100 5672521 Latest advice from the SMC http://www.medworm.com/index.php?rid=5672520&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00035 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672520 Thu, 09 Feb 2012 14:54:20 +0100 5672520 Ireland could cut branded drug prices substantially, says report http://www.medworm.com/index.php?rid=5672519&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00034 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672519 Thu, 09 Feb 2012 14:54:20 +0100 5672519 NICE gives final guidance on apixaban for VTE http://www.medworm.com/index.php?rid=5672518&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00033 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672518 Thu, 09 Feb 2012 14:54:20 +0100 5672518 Neoadjuvant CRT prior to surgery cost effective for pancreatic cancer http://www.medworm.com/index.php?rid=5672517&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00032 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672517 Thu, 09 Feb 2012 14:54:20 +0100 5672517 Poorer tolerance and higher costs after switch to capecitabine http://www.medworm.com/index.php?rid=5672516&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00031 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672516 Thu, 09 Feb 2012 14:54:20 +0100 5672516 Israel is to add 77 new treatments to its basket of drugs for reimbursement http://www.medworm.com/index.php?rid=5672515&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00030 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672515 Thu, 09 Feb 2012 14:54:20 +0100 5672515 Risk-adaptive use of plerixafor effective and saves costs http://www.medworm.com/index.php?rid=5672514&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00029 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672514 Thu, 09 Feb 2012 14:54:20 +0100 5672514 Self-monitoring blood glucose costs high for T1DM patients http://www.medworm.com/index.php?rid=5672513&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00028 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672513 Thu, 09 Feb 2012 14:54:20 +0100 5672513 Treating hypertension is highly cost effective in Greece http://www.medworm.com/index.php?rid=5672512&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00027 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672512 Thu, 09 Feb 2012 14:54:20 +0100 5672512 G-CSF cost-neutral for early-stage breast cancer http://www.medworm.com/index.php?rid=5672511&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00026 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672511 Thu, 09 Feb 2012 14:54:20 +0100 5672511 Uterine fibroids a substantial burden to US society http://www.medworm.com/index.php?rid=5672510&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00025 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672510 Thu, 09 Feb 2012 14:54:20 +0100 5672510 Effect of increased reimbursement on adolescent vaccine uptake http://www.medworm.com/index.php?rid=5672509&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00024 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672509 Thu, 09 Feb 2012 14:54:20 +0100 5672509 Routine PCV-10 vaccination best choice for Colombian children http://www.medworm.com/index.php?rid=5672508&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00023 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672508 Thu, 09 Feb 2012 14:54:20 +0100 5672508 Semi-annual surveillance for HCC cost effective in cirrhotic patients? http://www.medworm.com/index.php?rid=5672507&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00022 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672507 Thu, 09 Feb 2012 14:54:20 +0100 5672507 Which cervical cancer screening interval and test is best? http://www.medworm.com/index.php?rid=5672506&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00021 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672506 Thu, 09 Feb 2012 14:54:20 +0100 5672506 Maintenance pemetrexed not cost effective in Switzerland http://www.medworm.com/index.php?rid=5672505&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00020 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672505 Thu, 09 Feb 2012 14:54:20 +0100 5672505 First-line FOLFIRINOX attractive cost-effective treatment for mPC http://www.medworm.com/index.php?rid=5672504&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00019 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672504 Thu, 09 Feb 2012 14:54:20 +0100 5672504 Non-formulary PPI use uncommon but costly in VA population http://www.medworm.com/index.php?rid=5672503&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00018 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672503 Thu, 09 Feb 2012 14:54:20 +0100 5672503 Pneumonia a substantial burden to Australian health system http://www.medworm.com/index.php?rid=5672502&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00017 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672502 Thu, 09 Feb 2012 14:54:20 +0100 5672502 Costs of treating chronic hep B vary according to guideline used http://www.medworm.com/index.php?rid=5672501&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00016 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672501 Thu, 09 Feb 2012 14:54:20 +0100 5672501 Could broad-spectrum HPV vax reduce the need for screening? http://www.medworm.com/index.php?rid=5672500&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00015 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672500 Thu, 09 Feb 2012 14:54:20 +0100 5672500 Cotrimoxazole cost effective in first 6 months of ART http://www.medworm.com/index.php?rid=5672499&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00014 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672499 Thu, 09 Feb 2012 14:54:20 +0100 5672499 Double-unit UCBT best for acute leukaemia? http://www.medworm.com/index.php?rid=5672498&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00013 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672498 Thu, 09 Feb 2012 14:54:20 +0100 5672498 Best TB diagnostic strategy for patients initiating ART? http://www.medworm.com/index.php?rid=5672497&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00012 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672497 Thu, 09 Feb 2012 14:54:20 +0100 5672497 Both primary and booster coverage affected by US Hib vax shortage http://www.medworm.com/index.php?rid=5672496&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00011 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672496 Thu, 09 Feb 2012 14:54:20 +0100 5672496 Cost-effective treatments for colorectal cancer http://www.medworm.com/index.php?rid=5672495&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00010 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672495 Thu, 09 Feb 2012 14:54:20 +0100 5672495 Costs prevent 10% of Canadians from adhering to therapy http://www.medworm.com/index.php?rid=5672494&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00009 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672494 Thu, 09 Feb 2012 14:54:20 +0100 5672494 Catastrophic medical costs for diabetics in low-income countries http://www.medworm.com/index.php?rid=5672493&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00008 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672493 Thu, 09 Feb 2012 14:54:20 +0100 5672493 Rivaroxaban better than enoxaparin for post-surgical VTE http://www.medworm.com/index.php?rid=5672492&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00007 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672492 Thu, 09 Feb 2012 14:54:20 +0100 5672492 Fully-funded influenza vaccination of elderly worth it in Poland http://www.medworm.com/index.php?rid=5672491&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00006 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672491 Thu, 09 Feb 2012 14:54:20 +0100 5672491 New treatment guidelines for plaque psoriasis in the USA http://www.medworm.com/index.php?rid=5672490&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00005 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672490 Thu, 09 Feb 2012 14:54:20 +0100 5672490 Reliance on private sector could spell danger for UK's NHS http://www.medworm.com/index.php?rid=5672489&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00004 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672489 Thu, 09 Feb 2012 14:54:20 +0100 5672489 Chronic illness and disability costs crippling some Australians http://www.medworm.com/index.php?rid=5672488&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00003 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672488 Thu, 09 Feb 2012 14:54:20 +0100 5672488 NHS reforms complicating the push for efficiency gains http://www.medworm.com/index.php?rid=5672487&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000646%2Fart00002 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5672487 Thu, 09 Feb 2012 14:54:20 +0100 5672487 The influenza vaccine market is projected to reach $US4 billion by 2015, despite a decline in 2011 http://www.medworm.com/index.php?rid=5633897&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00038 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633897 Fri, 27 Jan 2012 15:13:30 +0100 5633897 Australian PBS to make substantial price cuts http://www.medworm.com/index.php?rid=5633896&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00037 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633896 Fri, 27 Jan 2012 15:13:30 +0100 5633896 Progress in China's healthcare reforms http://www.medworm.com/index.php?rid=5633895&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00036 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633895 Fri, 27 Jan 2012 15:13:30 +0100 5633895 NICE wants more info on rivaroxaban for AF . . . http://www.medworm.com/index.php?rid=5633894&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00035 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633894 Fri, 27 Jan 2012 15:13:30 +0100 5633894 Total US healthcare expenditure reached $US2.6 trillion in 2010 http://www.medworm.com/index.php?rid=5633893&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00034 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633893 Fri, 27 Jan 2012 15:13:30 +0100 5633893 Surgical or medical management of early pregnancy loss? http://www.medworm.com/index.php?rid=5633892&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00033 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633892 Fri, 27 Jan 2012 15:13:30 +0100 5633892 No major negative QOL effect from examestane chemoprevention http://www.medworm.com/index.php?rid=5633891&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00032 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633891 Fri, 27 Jan 2012 15:13:30 +0100 5633891 Screening for gestational diabetes highly cost effective in India http://www.medworm.com/index.php?rid=5633890&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00031 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633890 Fri, 27 Jan 2012 15:13:30 +0100 5633890 Percutaneous biopsy best for diagnosis of small renal mass http://www.medworm.com/index.php?rid=5633889&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00030 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633889 Fri, 27 Jan 2012 15:13:30 +0100 5633889 Posaconazole prophylaxis a winner in patients with GVHD http://www.medworm.com/index.php?rid=5633888&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00029 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633888 Fri, 27 Jan 2012 15:13:30 +0100 5633888 Lanthanum cost effective for US patients with ESRD http://www.medworm.com/index.php?rid=5633887&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00028 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633887 Fri, 27 Jan 2012 15:13:30 +0100 5633887 Does guideline adherence improve antibacterial therapy? http://www.medworm.com/index.php?rid=5633886&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00027 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633886 Fri, 27 Jan 2012 15:13:30 +0100 5633886 No financial benefit for providers to use combination vaccines http://www.medworm.com/index.php?rid=5633885&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00026 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633885 Fri, 27 Jan 2012 15:13:30 +0100 5633885 Prophylactic or on-demand therapy for severe haemophilia A? http://www.medworm.com/index.php?rid=5633884&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00025 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633884 Fri, 27 Jan 2012 15:13:30 +0100 5633884 Postmenopausal osteoporosis screening: which test is best? http://www.medworm.com/index.php?rid=5633883&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00024 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633883 Fri, 27 Jan 2012 15:13:30 +0100 5633883 Active surveillance best for prostate cancer? http://www.medworm.com/index.php?rid=5633882&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00023 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633882 Fri, 27 Jan 2012 15:13:30 +0100 5633882 Which diagnostic technique is most cost effective for TB? http://www.medworm.com/index.php?rid=5633881&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00022 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633881 Fri, 27 Jan 2012 15:13:30 +0100 5633881 Oncotype DX testing a winner for guiding breast cancer therapy http://www.medworm.com/index.php?rid=5633880&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00021 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633880 Fri, 27 Jan 2012 15:13:30 +0100 5633880 High cost savings with perinatal substance abuse programme http://www.medworm.com/index.php?rid=5633879&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00020 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633879 Fri, 27 Jan 2012 15:13:30 +0100 5633879 Switch to lopinavir/ritonavir cost effective in Uganda and Kenya http://www.medworm.com/index.php?rid=5633878&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00019 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633878 Fri, 27 Jan 2012 15:13:30 +0100 5633878 Is BRCA 1/2 genetic testing cost effective in the USA? http://www.medworm.com/index.php?rid=5633877&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00018 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633877 Fri, 27 Jan 2012 15:13:30 +0100 5633877 Paediatric vagus nerve stimulation saves costs in the USA http://www.medworm.com/index.php?rid=5633876&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00017 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633876 Fri, 27 Jan 2012 15:13:30 +0100 5633876 Birth-cohort screening beats risk-based screening for HCV http://www.medworm.com/index.php?rid=5633875&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00016 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633875 Fri, 27 Jan 2012 15:13:30 +0100 5633875 Cardiac stress testing not worth it for guiding CHD treatment http://www.medworm.com/index.php?rid=5633874&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00015 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633874 Fri, 27 Jan 2012 15:13:30 +0100 5633874 Medicaid cost control has lead to less use of antipsychotics http://www.medworm.com/index.php?rid=5633873&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00014 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633873 Fri, 27 Jan 2012 15:13:30 +0100 5633873 Lenalidomide plus dexamethasone a winner as second-line therapy http://www.medworm.com/index.php?rid=5633872&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00013 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633872 Fri, 27 Jan 2012 15:13:30 +0100 5633872 Adjuvant trastuzumab unjustified in patients with lower-risk disease http://www.medworm.com/index.php?rid=5633871&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00012 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633871 Fri, 27 Jan 2012 15:13:30 +0100 5633871 Entecavir proves its worth over the long-term in Hong Kong http://www.medworm.com/index.php?rid=5633870&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00011 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633870 Fri, 27 Jan 2012 15:13:30 +0100 5633870 Nilotinib better than imatinib, dasatinib for CML in Colombia http://www.medworm.com/index.php?rid=5633869&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00010 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633869 Fri, 27 Jan 2012 15:13:30 +0100 5633869 Nationwide, community-based lifestyle programme cost saving http://www.medworm.com/index.php?rid=5633868&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00009 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633868 Fri, 27 Jan 2012 15:13:30 +0100 5633868 NICE's STA process assessed http://www.medworm.com/index.php?rid=5633867&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00008 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633867 Fri, 27 Jan 2012 15:13:30 +0100 5633867 Access to prescription drugs in the US remains stable http://www.medworm.com/index.php?rid=5633866&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00007 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633866 Fri, 27 Jan 2012 15:13:30 +0100 5633866 Lactulose drives down costs of encephalopathy-related MVAs http://www.medworm.com/index.php?rid=5633865&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00006 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633865 Fri, 27 Jan 2012 15:13:30 +0100 5633865 One in four NHS trusts exclude NICE-approved drugs http://www.medworm.com/index.php?rid=5633864&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00005 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633864 Fri, 27 Jan 2012 15:13:30 +0100 5633864 98% of GPs want UK health reform bill withdrawn http://www.medworm.com/index.php?rid=5633863&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00004 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633863 Fri, 27 Jan 2012 15:13:30 +0100 5633863 The European Commission has released a 5-year action plan aimed at reducing the inappropriate use of antibacterials http://www.medworm.com/index.php?rid=5633862&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00003 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633862 Fri, 27 Jan 2012 15:13:30 +0100 5633862 NICE issues draft guidelines for early-onset neonatal infections . . . http://www.medworm.com/index.php?rid=5633861&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000645%2Fart00002 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5633861 Fri, 27 Jan 2012 15:13:30 +0100 5633861 A new Pioneer Accountable Care Organisation (ACO) initiative could save up to $US1.1 billion http://www.medworm.com/index.php?rid=5591110&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00036 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591110 Sun, 15 Jan 2012 04:11:42 +0100 5591110 Potential problems for pirfenidone in Germany http://www.medworm.com/index.php?rid=5591109&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00035 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591109 Sun, 15 Jan 2012 04:11:42 +0100 5591109 The stem cell market is projected to reach $US1.35 billion by 2015, up from a current market size of $883 million http://www.medworm.com/index.php?rid=5591108&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00034 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591108 Sun, 15 Jan 2012 04:11:42 +0100 5591108 Up to one third of the MRSA drug market will be dominated by Teflaro and tedizolid by 2020 http://www.medworm.com/index.php?rid=5591107&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00033 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591107 Sun, 15 Jan 2012 04:11:42 +0100 5591107 The dyslipidaemia drug market is forecast to decline by nearly $US6 billion by 2020, with generic erosion of blockbuster drugs being the main reason http://www.medworm.com/index.php?rid=5591106&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00032 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591106 Sun, 15 Jan 2012 04:11:42 +0100 5591106 Revenues from the pharma market in China are expected to reach $US116.8 billion in 2015 http://www.medworm.com/index.php?rid=5591105&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00031 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591105 Sun, 15 Jan 2012 04:11:42 +0100 5591105 Patients with relapsed follicular lymphoma will now have publicly-funded access to rituximab [Rituxan] in Ontario, Canada. http://www.medworm.com/index.php?rid=5591104&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00030 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591104 Sun, 15 Jan 2012 04:11:42 +0100 5591104 Innovative new drugs approved for reimbursement in Italy http://www.medworm.com/index.php?rid=5591103&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00029 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591103 Sun, 15 Jan 2012 04:11:42 +0100 5591103 Latest advice from the SMC http://www.medworm.com/index.php?rid=5591102&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00028 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591102 Sun, 15 Jan 2012 04:11:42 +0100 5591102 Pfizer and GSK extend pneumonia vaccine agreements with GAVI http://www.medworm.com/index.php?rid=5591101&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00027 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591101 Sun, 15 Jan 2012 04:11:42 +0100 5591101 NICE recommends four drugs http://www.medworm.com/index.php?rid=5591100&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00026 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591100 Sun, 15 Jan 2012 04:11:42 +0100 5591100 TAVI good value for patients with severe aortic stenosis http://www.medworm.com/index.php?rid=5591099&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00025 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591099 Sun, 15 Jan 2012 04:11:42 +0100 5591099 Ruxolitinib has a positive impact on QOL in myelofibrosis patients http://www.medworm.com/index.php?rid=5591098&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00024 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591098 Sun, 15 Jan 2012 04:11:42 +0100 5591098 Prostate Health Index: a valuable addition to PSA testing? http://www.medworm.com/index.php?rid=5591097&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00023 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591097 Sun, 15 Jan 2012 04:11:42 +0100 5591097 Erlotinib, docetaxel better value than pemetrexed for NSCLC http://www.medworm.com/index.php?rid=5591096&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00022 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591096 Sun, 15 Jan 2012 04:11:42 +0100 5591096 Intensive antibiotic prophylaxis best during TRUS biopsy http://www.medworm.com/index.php?rid=5591095&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00021 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591095 Sun, 15 Jan 2012 04:11:42 +0100 5591095 Opioid-related AEs extract large cost burden in the US http://www.medworm.com/index.php?rid=5591094&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00020 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591094 Sun, 15 Jan 2012 04:11:42 +0100 5591094 T2DM a costly disease to manage in Cameroon http://www.medworm.com/index.php?rid=5591093&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00019 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591093 Sun, 15 Jan 2012 04:11:42 +0100 5591093 Most cost-effective therapies for urinary incontinence in Sweden . . . http://www.medworm.com/index.php?rid=5591092&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00018 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591092 Sun, 15 Jan 2012 04:11:42 +0100 5591092 Pfizer fighting hard to hold on to Lipitor's market share http://www.medworm.com/index.php?rid=5591091&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00017 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591091 Sun, 15 Jan 2012 04:11:42 +0100 5591091 Gene testing worth it for hypertrophic cardiomyopathy http://www.medworm.com/index.php?rid=5591090&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00016 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591090 Sun, 15 Jan 2012 04:11:42 +0100 5591090 Herpes zoster vax cost effective in older adults in Belgium? http://www.medworm.com/index.php?rid=5591089&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00015 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591089 Sun, 15 Jan 2012 04:11:42 +0100 5591089 Sonographic-guided intra-articular injection best for osteoarthritis http://www.medworm.com/index.php?rid=5591088&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00014 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591088 Sun, 15 Jan 2012 04:11:42 +0100 5591088 Lipocalin: cost-effective biomarker of AKI after cardiac surgery http://www.medworm.com/index.php?rid=5591087&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00013 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591087 Sun, 15 Jan 2012 04:11:42 +0100 5591087 HeartMate II misses the beat for patients waiting for transplant http://www.medworm.com/index.php?rid=5591086&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00012 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591086 Sun, 15 Jan 2012 04:11:42 +0100 5591086 Adding docetaxel to induction chemo a winner for SCCHN http://www.medworm.com/index.php?rid=5591085&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00011 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591085 Sun, 15 Jan 2012 04:11:42 +0100 5591085 News from AHA http://www.medworm.com/index.php?rid=5591084&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00010 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591084 Sun, 15 Jan 2012 04:11:42 +0100 5591084 Genomic test-guided chemo cost effective for early BC? http://www.medworm.com/index.php?rid=5591083&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00009 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591083 Sun, 15 Jan 2012 04:11:42 +0100 5591083 BMA now fully oppose UK reform bill http://www.medworm.com/index.php?rid=5591082&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00008 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591082 Sun, 15 Jan 2012 04:11:42 +0100 5591082 Access to cancer drugs improves with UK government's fund http://www.medworm.com/index.php?rid=5591081&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00007 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591081 Sun, 15 Jan 2012 04:11:42 +0100 5591081 Lamivudine a winner for preventing vertical transmission of HBV http://www.medworm.com/index.php?rid=5591080&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00006 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591080 Sun, 15 Jan 2012 04:11:42 +0100 5591080 The American Association of Clinical Endocrinologists (AACE) has released new guidelines on the diagnosis and treatment of menopause. http://www.medworm.com/index.php?rid=5591079&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00005 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591079 Sun, 15 Jan 2012 04:11:42 +0100 5591079 New NICE guidelines for suspected anaphylactic episodes http://www.medworm.com/index.php?rid=5591078&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00004 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591078 Sun, 15 Jan 2012 04:11:42 +0100 5591078 Millions forced into poverty due to high drug costs http://www.medworm.com/index.php?rid=5591077&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00003 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591077 Sun, 15 Jan 2012 04:11:42 +0100 5591077 Most public health interventions highly cost effective http://www.medworm.com/index.php?rid=5591076&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2012%2F00000001%2F00000644%2Fart00002 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5591076 Sun, 15 Jan 2012 04:11:42 +0100 5591076 Lipitor [atorvastatin], the world's best-selling drug, has gone off-patent in the USA http://www.medworm.com/index.php?rid=5510867&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00034 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510867 Sat, 17 Dec 2011 03:21:49 +0100 5510867 From September 2012 in the UK, the quadrivalent human papillomavirus (HPV) vaccine, Gardasil, will replace the bivalent Cervarix vaccine http://www.medworm.com/index.php?rid=5510866&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00033 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510866 Sat, 17 Dec 2011 03:21:49 +0100 5510866 Latest guidance from NICE http://www.medworm.com/index.php?rid=5510865&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00032 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510865 Sat, 17 Dec 2011 03:21:49 +0100 5510865 The Romanian healthcare system is set switch from a state-based health insurance scheme to one based on private insurance companies http://www.medworm.com/index.php?rid=5510864&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00031 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510864 Sat, 17 Dec 2011 03:21:49 +0100 5510864 India's Supreme Court is warning the central government that drug prices are too high and should not be increased further http://www.medworm.com/index.php?rid=5510863&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00030 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510863 Sat, 17 Dec 2011 03:21:49 +0100 5510863 SMC issues latest advice http://www.medworm.com/index.php?rid=5510862&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00029 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510862 Sat, 17 Dec 2011 03:21:49 +0100 5510862 Greater access to denosumab and boceprevir in Canada http://www.medworm.com/index.php?rid=5510861&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00028 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510861 Sat, 17 Dec 2011 03:21:49 +0100 5510861 Infliximab beats adalimumab for moderate-to-severe UC http://www.medworm.com/index.php?rid=5510860&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00027 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510860 Sat, 17 Dec 2011 03:21:49 +0100 5510860 Ivabradine at the heart of QOL improvements for CHF http://www.medworm.com/index.php?rid=5510859&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00026 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510859 Sat, 17 Dec 2011 03:21:49 +0100 5510859 Could a patient-based formula guide funding allocation in the UK? http://www.medworm.com/index.php?rid=5510858&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00025 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510858 Sat, 17 Dec 2011 03:21:49 +0100 5510858 Paediatric vaccination with PCV13 good value for money http://www.medworm.com/index.php?rid=5510857&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00024 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510857 Sat, 17 Dec 2011 03:21:49 +0100 5510857 Golimumab, adalimumab and etanercept add up for AS http://www.medworm.com/index.php?rid=5510856&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00023 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510856 Sat, 17 Dec 2011 03:21:49 +0100 5510856 Biologicals not cost effective for RA in the real world http://www.medworm.com/index.php?rid=5510855&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00022 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510855 Sat, 17 Dec 2011 03:21:49 +0100 5510855 Dose-individualisation prior to IVF cost effective http://www.medworm.com/index.php?rid=5510854&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00021 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510854 Sat, 17 Dec 2011 03:21:49 +0100 5510854 Burden of melanoma more than skin deep for USA http://www.medworm.com/index.php?rid=5510853&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00020 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510853 Sat, 17 Dec 2011 03:21:49 +0100 5510853 Canada's Common Drug Review: a positive effect on drug coverage? http://www.medworm.com/index.php?rid=5510852&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00019 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510852 Sat, 17 Dec 2011 03:21:49 +0100 5510852 Erlotinib = docetaxel for second-line treatment of NSCLC http://www.medworm.com/index.php?rid=5510851&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00018 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510851 Sat, 17 Dec 2011 03:21:49 +0100 5510851 D-Dimer screening: does it add up for aortic dissection? http://www.medworm.com/index.php?rid=5510850&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00017 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510850 Sat, 17 Dec 2011 03:21:49 +0100 5510850 Early and more effective treatments increase HIV costs http://www.medworm.com/index.php?rid=5510849&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00016 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510849 Sat, 17 Dec 2011 03:21:49 +0100 5510849 High uptake of free HPV vaccine in Denmark . . . http://www.medworm.com/index.php?rid=5510848&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00015 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510848 Sat, 17 Dec 2011 03:21:49 +0100 5510848 Boceprevir a valuable addition for hepatitis C http://www.medworm.com/index.php?rid=5510847&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00014 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510847 Sat, 17 Dec 2011 03:21:49 +0100 5510847 Oxaliplatin versus irinotecan for elderly patients with colon cancer? http://www.medworm.com/index.php?rid=5510846&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00013 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510846 Sat, 17 Dec 2011 03:21:49 +0100 5510846 Hospitalisation "cost prohibitive" vs same-day clinic for TIA http://www.medworm.com/index.php?rid=5510845&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00012 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510845 Sat, 17 Dec 2011 03:21:49 +0100 5510845 Routine CD4 cell counts worth it vs viral load testing during ART http://www.medworm.com/index.php?rid=5510844&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00011 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510844 Sat, 17 Dec 2011 03:21:49 +0100 5510844 Arthritis burden huge in Canada http://www.medworm.com/index.php?rid=5510843&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00010 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510843 Sat, 17 Dec 2011 03:21:49 +0100 5510843 Will removing co-payments improve outcomes for MI? http://www.medworm.com/index.php?rid=5510842&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00009 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510842 Sat, 17 Dec 2011 03:21:49 +0100 5510842 Costs of migraine a growing headache for the USA? http://www.medworm.com/index.php?rid=5510841&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00008 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510841 Sat, 17 Dec 2011 03:21:49 +0100 5510841 First-line tenofovir best for chronic hepatitis B in Canada http://www.medworm.com/index.php?rid=5510840&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00007 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510840 Sat, 17 Dec 2011 03:21:49 +0100 5510840 The UK's NICE has published draft recommendations on the safe and effective prescribing of strong opioids in palliative care. http://www.medworm.com/index.php?rid=5510839&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00006 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510839 Sat, 17 Dec 2011 03:21:49 +0100 5510839 Updated National Comprehensive Cancer Network (NCCN) melanoma guidelines for patients and their caregivers have been published http://www.medworm.com/index.php?rid=5510838&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00005 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510838 Sat, 17 Dec 2011 03:21:49 +0100 5510838 NICE heart of new Commissioning Outcomes Framework http://www.medworm.com/index.php?rid=5510837&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00004 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510837 Sat, 17 Dec 2011 03:21:49 +0100 5510837 UK healthcare spending exceeds OECD average in 2009 http://www.medworm.com/index.php?rid=5510836&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00003 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510836 Sat, 17 Dec 2011 03:21:49 +0100 5510836 Medicines as an investment, not a cost, for the NHS http://www.medworm.com/index.php?rid=5510835&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00002 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510835 Sat, 17 Dec 2011 03:21:49 +0100 5510835 Medicare Part D prescription drug coverage varies widely http://www.medworm.com/index.php?rid=5510834&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000643%2Fart00001 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5510834 Thu, 15 Dec 2011 02:06:28 +0100 5510834 Risks of NHS reforms to be disclosed by health secretary http://www.medworm.com/index.php?rid=5453197&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000642%2Fart00031 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5453197 Tue, 29 Nov 2011 03:49:39 +0100 5453197 Latest PCI and CABG guideline updates from ACC/AHA/SCAI http://www.medworm.com/index.php?rid=5453196&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000642%2Fart00030 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5453196 Tue, 29 Nov 2011 03:49:39 +0100 5453196 NICE releases guidance for colorectal cancer and T2DM http://www.medworm.com/index.php?rid=5453195&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000642%2Fart00029 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5453195 Tue, 29 Nov 2011 03:49:39 +0100 5453195 Low-dose aspirin plus endoscopy cost effective for CRC prevention http://www.medworm.com/index.php?rid=5453194&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000642%2Fart00028 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5453194 Tue, 29 Nov 2011 03:49:39 +0100 5453194 Clodronic acid best for metastatic bone disease in Brazil http://www.medworm.com/index.php?rid=5453193&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000642%2Fart00027 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5453193 Tue, 29 Nov 2011 03:49:39 +0100 5453193 Cluster headaches costly http://www.medworm.com/index.php?rid=5453192&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000642%2Fart00026 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5453192 Tue, 29 Nov 2011 03:49:39 +0100 5453192 Self-monitoring for T2DM in Canada: what do the models say? http://www.medworm.com/index.php?rid=5453191&cid=s_33941_51_f&fid=33941&url=http%3A%2F%2Fwww.ingentaconnect.com%2Fcontent%2Fadis%2Fpeon%2F2011%2F00000001%2F00000642%2Fart00025 (Source: PharmacoEconomics and Outcomes News) PharmacoEconomics and Outcomes News journals http://www.medworm.com/rss/comments.php?id=5453191 Tue, 29 Nov 2011 03:49:39 +0100 5453191